NASDAQ: SWMR
Swarmer, IncCIK 0002092574 · SIC 7372 · Prepackaged Software
Micro
Revenue $310K
Assets $34M
as of Sep 20, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (UEC 10-K) is open in full — no account needed.
8-K
Filed Sep 10, 2026
· Period ending Sep 9, 2026
Summary not yet generated.
424B3
Filed Aug 19, 2026
Summary not yet generated.
Partner
Trade SWMR commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed Aug 19, 2026
· Period ending Aug 19, 2026
Summary not yet generated.
424B3
Filed Aug 17, 2026
Red flag
Swarmer, Inc. completed its IPO on March 18, 2026, selling 3,450,000 shares at $5.00 per share for gross proceeds of $17.3 million.
6 material changes detected. Sign up free to read the summary.
10-Q
Filed Aug 14, 2026
· Period ending Jun 30, 2026
Summary not yet generated.
8-K
Filed Aug 14, 2026
· Period ending Aug 14, 2026
Summary not yet generated.
8-K
Filed Aug 13, 2026
· Period ending Aug 13, 2026
Summary not yet generated.
8-K
Filed Jul 29, 2026
· Period ending Jul 26, 2026
Summary not yet generated.
8-K
Filed Jul 27, 2026
· Period ending Jul 24, 2026
Summary not yet generated.
8-K
Filed Jun 30, 2026
· Period ending Jun 25, 2026
Summary not yet generated.
8-K
Filed Jun 29, 2026
· Period ending Jun 23, 2026
Summary not yet generated.
424B3
Filed Jun 15, 2026
Summary not yet generated.
S-1
Filed Jun 10, 2026
Summary not yet generated.
8-K
Filed Jun 10, 2026
· Period ending Jun 10, 2026
Summary not yet generated.
10-Q
Filed May 14, 2026
· Period ending Mar 31, 2026
Summary not yet generated.
8-K
Filed May 13, 2026
· Period ending May 13, 2026
Summary not yet generated.
424B4
Filed Mar 17, 2026
Swarmer, Inc. prices IPO of 3,000,000 shares at $5.00 per share, raising $15 million gross
4 material changes detected. Sign up free to read the summary.
S-1/A
Filed Feb 19, 2026
Summary not yet generated.
S-1
Filed Feb 2, 2026
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 14, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | 216,413 | 138,206 | 236,738 | 248,910 |
| Cost of revenue | 32,816 | 56,176 | 72,740 | 101,718 |
| Gross margin | 183,597 | 82,030 | 163,998 | 147,192 |
| Operating expenses: | ||||
| Selling, general and administrative | 5,657,638 | 277,591 | 8,662,517 | 532,872 |
| Research and development | 1,805,532 | 577,256 | 3,291,614 | 1,099,454 |
| Total operating expenses | 7,463,170 | 854,847 | 11,954,131 | 1,632,326 |
| Loss from operations | (7,279,573) | (772,817) | (11,790,133) | (1,485,134) |
| Other income (expense): | ||||
| Change in fair value of Simple Agreement for Future Equity ("SAFE") liability | — | (869,000) | — | (869,000) |
| Change in fair value of Equity Line of Credit ("ELOC") derivative | (251,455) | — | (251,455) | — |
| Other income | 205,990 | 14,635 | 257,715 | 32,975 |
| Loss before income taxes | (7,325,038) | (1,627,182) | (11,783,873) | (2,321,159) |
| Income tax expense | — | — | — | — |
| Net loss | (7,325,038) | (1,627,182) | (11,783,873) | (2,321,159) |
| Net loss per share of common stock, basic and diluted | (0.45) | (0.51) | (1.03) | (0.78) |
| Weighted-average shares of common stock outstanding, basic and diluted | 16,333,844 | 3,211,540 | 11,414,411 | 2,970,764 |
| Comprehensive loss: | ||||
| Foreign currency translation adjustments | 223,943 | 14,478 | 200,402 | 14,744 |
| Total comprehensive loss | (7,101,095) | (1,612,704) | (11,583,471) | (2,306,415) |
Condensed Consolidated Balance Sheets (Unaudited)
| Description | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | 25,289,260 | 9,283,566 |
| Accounts receivable | 95,580 | — |
| Receivable from sale of common stock | 4,625,269 | — |
| UAV deployment program advance payment | 1,845,000 | — |
| Prepaid expenses and other current assets | 1,137,379 | 115,473 |
| Total current assets | 32,992,488 | 9,399,039 |
| Property and equipment, net | 470,586 | 227,908 |
| Operating lease right-of-use asset | 99,610 | 131,184 |
| Intangible assets | 97,668 | — |
| Deferred offering costs | — | 471,719 |
| Other assets | 275,333 | 106,830 |
| Total assets | 33,935,685 | 10,336,680 |
| Liabilities, convertible preferred stock and shareholders' equity (deficit) | ||
| Current liabilities: | ||
| Accounts payable | 204,803 | 223,236 |
| Accrued expenses and other current liabilities | 1,329,493 | 680,782 |
| Grant advance | 178,381 | 189,200 |
| Deferred revenue | 107,121 | 23,272 |
| Operating lease liability current | 73,453 | 70,703 |
| Advances received under combined arrangement | 793,092 | — |
| Total current liabilities | 2,686,343 | 1,187,193 |
| Operating lease liability non-current | 38,757 | 76,273 |
| Total liabilities | 2,725,100 | 1,263,466 |
| Convertible preferred stock, par value $0.00001 per share: | ||
| Series A preferred stock: no shares authorized, issued or outstanding as of June 30, 2026; 4,358,597 shares authorized and 3,661,083 shares issued and outstanding as of December 31, 2025 | — | 19,013,673 |
| Commitments and contingencies (Note 10) | ||
| Shareholders' equity (deficit) | ||
| Preferred stock, $0.00001 par value; 10,000,000 shares authorized and no shares issued and outstanding as of June 30, 2026; no shares authorized, issued or outstanding as of December 31, 2025 | — | — |
| Common stock, $0.00001 par value; 200,000,000 and 25,000,000 shares authorized as of June 30, 2026 and December 31, 2025, respectively; 11,608,117 and 1,410,975 shares issued as of June 30, 2026 and December 31, 2025, respectively; and 11,284,769 and 911,255 shares outstanding as of June 30, 2026 and December 31, 2025, respectively | 113 | 10 |
| Additional paid-in capital | 53,397,926 | 663,514 |
| Accumulated other comprehensive income (loss) | 195,502 | (4,900) |
| Accumulated deficit | (22,382,956) | (10,599,083) |
| Total shareholders' equity (deficit) | 31,210,585 | (9,940,459) |
| Total liabilities, convertible preferred stock and shareholders' equity (deficit) | 33,935,685 | 10,336,680 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Operating activities: | 2026 | 2025 |
| Net loss | (11,783,873) | (2,321,159) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation expense | 96,344 | — |
| Amortization of ROU asset | 31,574 | — |
| Change in fair value of ELOC derivative | 251,455 | — |
| Change in fair value of SAFE liability | — | 869,000 |
| Share-based compensation expense | 1,459,980 | 28,488 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (95,580) | — |
| Unbilled revenue | — | 3,193 |
| UAV deployment program advance payment | (1,845,000) | — |
| Prepaid expenses and other current assets | (557,503) | (9,147) |
| Other assets | (168,979) | (2,070) |
| Accounts payable | (18,019) | (421) |
| Accrued expenses and other liabilities | 649,219 | (3,237) |
| Deferred revenue | 84,626 | 3,853 |
| Advances received under combined arrangement | 793,092 | — |
| Operating lease liability | (34,766) | — |
| Net cash used in operating activities | (11,137,430) | (1,431,500) |
| Investing activities: | ||
| Purchase of property and equipment | (347,997) | — |
| Purchase of intangible assets | (97,668) | — |
| Cash used in investing activities | (445,665) | — |
| Financing activities: | ||
| Proceeds from initial public offering, net of underwriting discounts | 16,015,000 | — |
| Proceeds from ELOC | 8,826,408 | — |
| Proceeds from sale of Series A-1 convertible preferred stock | 3,472,095 | — |
| Payment of financing costs | (926,264) | — |
| Cash provided by financing activities | 27,387,239 | — |
| Effect of exchange rates on cash and cash equivalents | 201,550 | 14,261 |
| Net increase (decrease) in cash and cash equivalents | 16,005,694 | (1,417,239) |
| Cash and cash equivalents at the beginning of the period | 9,283,566 | 2,081,086 |
| Cash and cash equivalents at the end of the period | 25,289,260 | 663,847 |
| Supplemental non-cash investing and financing activities: | ||
| Conversion of Series A Preferred Stock into Common Stock | 22,485,768 | — |
| Common stock issued under ELOC in exchange for receivable from sale of common stock | 4,625,269 | — |
| Derivative asset recognized for draw priced but unsettled under the ELOC (Note 6) | 74,970 | — |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗